Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma.

about

Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma.

Item

http://www.wikidata.org/entity/Q49427808

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Therapeutic effect of targeted ...... el of human ovarian carcinoma.

@en

Therapeutic effect of targeted ...... el of human ovarian carcinoma.

@nl

type

Item

label

Therapeutic effect of targeted ...... el of human ovarian carcinoma.

@en

Therapeutic effect of targeted ...... el of human ovarian carcinoma.

@nl

prefLabel

Therapeutic effect of targeted ...... el of human ovarian carcinoma.

@en

Therapeutic effect of targeted ...... el of human ovarian carcinoma.

@nl

P1476

Therapeutic effect of targeted ...... el of human ovarian carcinoma.

@en

P2093

Fuyan Jiang

http://www.w3.org/2001/XMLSchema#string

Guangping Tan

http://www.w3.org/2001/XMLSchema#string

Hongying He

http://www.w3.org/2001/XMLSchema#string

Jiajing Lin

http://www.w3.org/2001/XMLSchema#string

Shuting Sheng

http://www.w3.org/2001/XMLSchema#string

Ying Lan

http://www.w3.org/2001/XMLSchema#string

P2860

Gene therapy: progress and predictions

A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.

Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters.

State-of-the-art human gene therapy: part II. Gene therapy strategies and clinical applications.

Sequential combination therapy with flavopiridol and autocatalytic caspase-3 driven by amplified hTERT promoter synergistically suppresses human ovarian carcinoma growth in vitro and in mice.

Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy.

Transcriptionally targeted gene therapy to detect and treat cancer.

Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy

High RhoA expression at the tumor front in clinically localized prostate cancer and association with poor tumor differentiation.

A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.

P304

2555-2561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.7599

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dingyuan Zeng

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29434973

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

P932

5777350

http://www.w3.org/2001/XMLSchema#string